We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Luminex Corporation

Luminex develops, manufactures, and markets biological testing technologies with applications in clinical diagnostics... read more Featured Products: More products

Download Mobile App




Noninvasive Test Identifies Childhood Metabolic Disease Risk

By LabMedica International staff writers
Posted on 25 Jun 2014
Print article
Luminex 100 multiplex analyzer
Multiplex analyzer (Photo courtesy of Luminex - A Diasorin Company)
Salivary biomarkers have been used as a tool for identifying children who are at risk for developing Type 2 diabetes (T2D).

The study of obesity-related metabolic syndrome or T2D in children is particularly difficult because of fear of needles; however a noninvasive approach to study inflammatory parameters in an at-risk population of children may provide proof-of-principle for future investigations of vulnerable subjects.

Scientists from the Forsyth Research Institute, Cambridge, MA, USA) working with colleague in Kuwait, evaluated metabolic differences in 744, 11-year old children selected from underweight, normal healthy weight, overweight and obese categories by analyzing fasting saliva samples for 20 biomarkers. Saliva supernatants were obtained following centrifugation and used for analyses.

All assays on the 744 saliva samples for the 20 biomarkers were performed on saliva supernatant using four multiplex magnetic bead panels on a Luminex 100 platform (Luminex, Austin, TX, USA). A subset of 213 saliva supernatants (approximately 54 from each body weight category) were randomly selected and assayed for total protein. The assay was performed using the commercial kit Pierce 660 nm protein assay, (Pierce Biotechnology Rockford, IL, USA) which has a working range of 50 to 2,000 µg/ml. Protein values were determined on saliva supernatant samples using bovine serum albumin as a standard implemented on a robotic chemical analysis unit, the EVO 100 with a Sunrise spectrophotometer set at 660 nm, (Tecan US; Morrisville NC, USA).

Salivary C-reactive protein (CRP) was six times higher, salivary insulin and leptin were three times higher, and adiponectin was 30% lower in obese children compared to healthy normal weight children. Categorical analysis suggested that there might be three types of obesity in children. Distinctly inflammatory characteristics appeared in 76% of obese children while in 13%, salivary insulin was high but not associated with inflammatory mediators. The remaining 11% of obese children had high insulin and reduced adiponectin. In the non-obese children 40% were found in groups which, based on biomarker characteristics, may be at risk for becoming obese.

The authors concluded that they had identified four salivary biomarkers in their study subjects that change significantly with increasing obesity; insulin, CRP, adiponectin, and leptin. The results of this study suggest that obesity may be characterized and classified by salivary biomarker concentrations. The use of these relatively noninvasive markers, particularly in longitudinal studies, to investigate the development of metabolic diseases in children and to evaluate therapeutic interventions, could be used to develop prevention strategies. The study was published on June 10, 2014, in the journal Public Library of Science ONE.

Related Links:

Forsyth Research Institute
Luminex
Pierce Biotechnology 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The real-time multiplex PCR test is set to revolutionize early sepsis detection (Photo courtesy of Shutterstock)

1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens

Sepsis contributes to one in every three hospital deaths in the US, and globally, septic shock carries a mortality rate of 30-40%. Diagnosing sepsis early is challenging due to its non-specific symptoms... Read more

Pathology

view channel
Image: The QIAseq xHYB Mycobacterium tuberculosis Panel uses next-generation sequencing (Photo courtesy of 123RF)

New Mycobacterium Tuberculosis Panel to Support Real-Time Surveillance and Combat Antimicrobial Resistance

Tuberculosis (TB), the leading cause of death from an infectious disease globally, is a contagious bacterial infection that primarily spreads through the coughing of patients with active pulmonary TB.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.